PLACCINE

What this means for you

This application is over — abandoned 23 Feb 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

97828639

Mark type

Stylized text

Filed

08 Mar 2023

Published for opposition

28 May 2024

Abandoned

23 Feb 2026

Attorney of record

Monica Riva Talley

Goods and services

• Class 042 — Scientific and technological services: Development of platform technology, namely, cancer immunotherapy, infectious disease vaccines, and gene therapy platforms for manufacturing therapeutics and vaccines; Biological and biotechnology research; research and development in the pharmaceutical and biotechnology fields; scientific research and development with regard to the manufacture of pharmaceutical preparations; chemical and biological analysis; development of pharmaceutical preparations for treating cancer; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological research in the fields of genetics, immunotherapy, vaccination, and oncology

Owner

• Imunon, Inc., Lawrenceville, NJ, US
• Imunon, Inc., Lawrenceville, NJ, US

Prosecution history

• 23 Feb 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
• 23 Feb 2026 — ABANDONMENT - NO USE STATEMENT FILED
• 23 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 22 Jul 2025 — SOU EXTENSION 2 GRANTED
• 22 Jul 2025 — SOU EXTENSION 2 FILED
• 22 Jul 2025 — SOU TEAS EXTENSION RECEIVED
• 04 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 17 Jan 2025 — SOU EXTENSION 1 GRANTED
• 17 Jan 2025 — SOU EXTENSION 1 FILED
• 17 Jan 2025 — SOU TEAS EXTENSION RECEIVED
• 23 Jul 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 28 May 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 28 May 2024 — PUBLISHED FOR OPPOSITION
• 08 May 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 22 Apr 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER